These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18802333)

  • 61. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling.
    D'Cruz LM; Klein L
    Nat Immunol; 2005 Nov; 6(11):1152-9. PubMed ID: 16227983
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.
    Schabowsky RH; Madireddi S; Sharma R; Yolcu ES; Shirwan H
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1002-8. PubMed ID: 18058571
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Deficiency of mouse CD4+CD25+Foxp3+ regulatory T cells in xenogeneic pig thymus-grafted nude mice suffering from autoimmune diseases.
    Zhang B; Sun C; Qu Y; Zhang A; Liu J; Zhang L; Niu Z; Zhao Y
    Cell Mol Immunol; 2008 Oct; 5(5):325-32. PubMed ID: 18954555
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sub-optimal CD4+ T-cell activation triggers autonomous TGF-β-dependent conversion to Foxp3+ regulatory T cells.
    Oliveira VG; Caridade M; Paiva RS; Demengeot J; Graca L
    Eur J Immunol; 2011 May; 41(5):1249-55. PubMed ID: 21469093
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A new approach to the role of IL-7 and TGF-ß in the in vitro generation of thymus-derived CD4+CD25+Foxp3+ regulatory T cells.
    Bieńkowska A; Kiernozek E; Kozlowska E; Bugajski Ł; Drela N
    Cytokine; 2018 Feb; 102():107-116. PubMed ID: 28826649
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3?
    Beyer M; Schultze JL
    Int Immunopharmacol; 2011 May; 11(5):555-60. PubMed ID: 21115121
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tumor suppressor p53 inhibits systemic autoimmune diseases by inducing regulatory T cells.
    Kawashima H; Takatori H; Suzuki K; Iwata A; Yokota M; Suto A; Minamino T; Hirose K; Nakajima H
    J Immunol; 2013 Oct; 191(7):3614-23. PubMed ID: 24006461
    [TBL] [Abstract][Full Text] [Related]  

  • 69. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
    Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
    Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
    Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
    Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intranasal ovalbumin immunotherapy with mycobacterial adjuvant promotes regulatory T cell accumulation in lung tissues.
    Akkoç T; Genç D; Zibandeh N; Akkoç T
    Microbiol Immunol; 2018 Aug; 62(8):531-540. PubMed ID: 29989252
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature.
    Hill JA; Feuerer M; Tash K; Haxhinasto S; Perez J; Melamed R; Mathis D; Benoist C
    Immunity; 2007 Nov; 27(5):786-800. PubMed ID: 18024188
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Naturally occurring tolerance acquisition to foods in previously allergic children is characterized by antigen specificity and associated with increased subsets of regulatory T cells.
    Qamar N; Fishbein AB; Erickson KA; Cai M; Szychlinski C; Bryce PJ; Schleimer RP; Fuleihan RL; Singh AM
    Clin Exp Allergy; 2015 Nov; 45(11):1663-72. PubMed ID: 25989379
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The molecular mechanisms of Foxp3 gene regulation.
    Maruyama T; Konkel JE; Zamarron BF; Chen W
    Semin Immunol; 2011 Dec; 23(6):418-23. PubMed ID: 21752667
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Distinct translational control in CD4+ T cell subsets.
    Bjur E; Larsson O; Yurchenko E; Zheng L; Gandin V; Topisirovic I; Li S; Wagner CR; Sonenberg N; Piccirillo CA
    PLoS Genet; 2013 May; 9(5):e1003494. PubMed ID: 23658533
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Current trends with FOXP3
    Trinath J; Bayry J
    Immunotherapy; 2019 Jun; 11(9):755-758. PubMed ID: 31094264
    [No Abstract]   [Full Text] [Related]  

  • 77. Thymic regulatory T cell development: role of signalling pathways and transcription factors.
    Engel M; Sidwell T; Vasanthakumar A; Grigoriadis G; Banerjee A
    Clin Dev Immunol; 2013; 2013():617595. PubMed ID: 24187564
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The development and function of regulatory T cells.
    Workman CJ; Szymczak-Workman AL; Collison LW; Pillai MR; Vignali DA
    Cell Mol Life Sci; 2009 Aug; 66(16):2603-22. PubMed ID: 19390784
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antigen-based therapies targeting the expansion of regulatory T cells in autoimmune and allergic disease.
    Leech M; Anderton S
    Chem Immunol Allergy; 2008; 94():201-210. PubMed ID: 18802349
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes.
    Feuerer M; Hill JA; Mathis D; Benoist C
    Nat Immunol; 2009 Jul; 10(7):689-95. PubMed ID: 19536194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.